Skip to content
Search

Latest Stories

No further price concessions for December, DHSC confirms

The Department of Health and Social Care (DHSC) has confirmed that the price concession announcement made on December 20, 2019 is final for the month and no further concessions will be granted.

The complete list, revealed by PSNC, is as follows:


DrugPack sizePrice Concession
Alverine 60mg capsules100£8.35
Amiloride 5mg tablets28£19.20
Cefalexin 125mg/5ml oral suspension100ml£1.95
Cefalexin 250mg/5ml oral suspension100ml£2.25
Co-careldopa 12.5mg/50mg tablets90£12.25
Co-careldopa 25mg/100mg tablets100£10.99
Colecalciferol 1,000unit capsules30£10.00
Cyclizine 50mg/1ml solution for injection ampoules5£11.98
Desmopressin 200microgram tablets30£19.85
Dexamfetamine 5mg/5ml oral solution sugar free500ml£381.63
Diclofenac sodium 75mg modified-release tablets56£9.70
Diclofenac sodium 100mg modified-release tablets28£10.40
Frovatriptan 2.5mg tablets6£11.91
Hydroxyzine 10mg tablets84£2.45
Hydroxyzine 25mg tablets28£0.97
Imipramine 25mg tablets28£2.99
Indapamide 2.5mg tablets28£2.50
Indoramin 20mg tablets60£10.64
Irbesartan 75mg tablets28£4.06
Irbesartan 150mg tablets28£7.09
Irbesartan 300mg tablets28£6.93
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets28£14.31
Lamotrigine 25mg dispersible tablets sugar free56£13.31
Lamotrigine 100mg dispersible tablets sugar free56£9.85
Levetiracetam 250mg tablets60£5.75
Levetiracetam 500mg tablets60£9.92
Levetiracetam 1g tablets60£10.99
Lymecycline 408mg capsules28£5.11
Meloxicam 7.5mg tablets30£3.45
Meloxicam 15mg tablets30£5.30
Memantine 10mg tablets28£4.00
Memantine 20mg tablets28£8.86
Mirtazapine 15mg tablets28£2.61
Mirtazapine 30mg tablets28£3.69
Mirtazapine 45mg tablets28£4.49
Mometasone 50micrograms/dose nasal spray140 dose£4.42
Montelukast 5mg chewable tablets sugar free28£1.86
Nefopam 30mg tablets90£19.79
Nifedipine 5mg capsules90£51.95
Nifedipine 10mg capsules90£65.63
Nifedipine 10mg modified-release tablets56£9.23
Nitrazepam 5mg tablets28£2.64
Nitrofurantoin 50mg tablets28£11.87
Nitrofurantoin 100mg tablets28£9.44
Oxytetracycline 250mg tablets28£5.35
Pizotifen 500microgram tablets28£1.80
Pizotifen 1.5mg tablets28£5.98
Propranolol 40mg tablets28£1.35
Quetiapine 25mg tablets60£2.70
Quinine sulfate 300mg tablets28£9.02
Ranitidine 150mg tablets60£4.15
Ranitidine 300mg tablets30£4.95
Rivastigmine 1.5mg capsules28£3.57
Rivastigmine 3mg capsules28£3.95
Sodium fluoride 0.05% mouthwash sugar free250ml£1.85
Tamoxifen 20mg tablets30£4.71
Tetracycline 250mg tablets28£4.79
Tizanidine 2mg tablets120£12.00
Trihexyphenidyl 2mg tablets84£9.08
Venlafaxine 37.5mg tablets56£7.18
Venlafaxine 75mg tablets56£13.97
Zolpidem 5mg tablets28£1.71

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less